FDA Approves 1st Therapy for L-amino Acid Decarboxylase Deficiency
14 Nov 2024 //
PR NEWSWIRE
Novartis Ribociclib (Kisqali®) Receives NCCN Category 1 Status
24 Oct 2024 //
GLOBENEWSWIRE
Aroma-Zone starts Belgian expansion with ambition
10 Nov 2022 //
RETAIL DETAIL
Eurazeo ready to invest EUR 410 million in Aroma-Zone’s home-made cosmetics
25 Apr 2021 //
PREMIUM BEAUTY
Eurazeo Set to Buy Aroma-Zone, the Natural, DIY Beauty Brand
24 Apr 2021 //
WWD